Back to Journals » OncoTargets and Therapy » Volume 9
Review
Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,652 | Dovepress* | 7,014+ | 1,279 | 8,293 | |
PubMed Central* | 1,638 | 285 | 1,923 | ||
Totals | 8,652 | 1,564 | 10,216 | ||
*Since 16 September 2016 |
View citations on PubMed Central and Google Scholar